157 related articles for article (PubMed ID: 37527038)
1. SLC15A4 controls endolysosomal TLR7-9 responses by recruiting the innate immune adaptor TASL.
Zhang H; Bernaleau L; Delacrétaz M; Hasanovic E; Drobek A; Eibel H; Rebsamen M
Cell Rep; 2023 Aug; 42(8):112916. PubMed ID: 37527038
[TBL] [Abstract][Full Text] [Related]
2. TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9.
Heinz LX; Lee J; Kapoor U; Kartnig F; Sedlyarov V; Papakostas K; César-Razquin A; Essletzbichler P; Goldmann U; Stefanovic A; Bigenzahn JW; Scorzoni S; Pizzagalli MD; Bensimon A; Müller AC; King FJ; Li J; Girardi E; Mbow ML; Whitehurst CE; Rebsamen M; Superti-Furga G
Nature; 2020 May; 581(7808):316-322. PubMed ID: 32433612
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for recruitment of TASL by SLC15A4 in human endolysosomal TLR signaling.
Chen X; Xie M; Zhang S; Monguió-Tortajada M; Yin J; Liu C; Zhang Y; Delacrétaz M; Song M; Wang Y; Dong L; Ding Q; Zhou B; Tian X; Deng H; Xu L; Liu X; Yang Z; Chang Q; Na J; Zeng W; Superti-Furga G; Rebsamen M; Yang M
Nat Commun; 2023 Oct; 14(1):6627. PubMed ID: 37863913
[TBL] [Abstract][Full Text] [Related]
4. A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-inflammatory activity.
Boeszoermenyi A; Bernaleau L; Chen X; Kartnig F; Xie M; Zhang H; Zhang S; Delacrétaz M; Koren A; Hopp AK; Dvorak V; Kubicek S; Aletaha D; Yang M; Rebsamen M; Heinz LX; Superti-Furga G
Nat Commun; 2023 Oct; 14(1):6626. PubMed ID: 37863876
[TBL] [Abstract][Full Text] [Related]
5. Human SLC15A4 is crucial for TLR-mediated type I interferon production and mitochondrial integrity.
Kobayashi T; Nguyen-Tien D; Ohshima D; Karyu H; Shimabukuro-Demoto S; Yoshida-Sugitani R; Toyama-Sorimachi N
Int Immunol; 2021 Jun; 33(7):399-406. PubMed ID: 33560415
[TBL] [Abstract][Full Text] [Related]
6. TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals.
Satterthwaite AB
Curr Rheumatol Rep; 2021 Nov; 23(11):80. PubMed ID: 34817709
[TBL] [Abstract][Full Text] [Related]
7. The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models.
Katewa A; Suto E; Hui J; Heredia J; Liang J; Hackney J; Anderson K; Alcantar TM; Bacarro N; Dunlap D; Eastham J; Paler-Martinez A; Rairdan XY; Modrusan Z; Lee WP; Austin CD; Lafkas D; Ghilardi N
PLoS One; 2021; 16(1):e0244439. PubMed ID: 33444326
[TBL] [Abstract][Full Text] [Related]
8. The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production.
Kobayashi T; Shimabukuro-Demoto S; Yoshida-Sugitani R; Furuyama-Tanaka K; Karyu H; Sugiura Y; Shimizu Y; Hosaka T; Goto M; Kato N; Okamura T; Suematsu M; Yokoyama S; Toyama-Sorimachi N
Immunity; 2014 Sep; 41(3):375-388. PubMed ID: 25238095
[TBL] [Abstract][Full Text] [Related]
9. The solute carrier SLC15A4 is required for optimal trafficking of nucleic acid-sensing TLRs and ligands to endolysosomes.
Rimann I; Gonzalez-Quintial R; Baccala R; Kiosses WB; Teijaro JR; Parker CG; Li X; Beutler B; Kono DH; Theofilopoulos AN
Proc Natl Acad Sci U S A; 2022 Apr; 119(14):e2200544119. PubMed ID: 35349343
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of STAT3 alleviates LPS-induced apoptosis and inflammation in renal tubular epithelial cells by transcriptionally down-regulating TASL.
Xu JW; Wang MY; Mao Y; Hu ZY; Miao XL; Jiang F; Zhou GP
Eur J Med Res; 2024 Jan; 29(1):34. PubMed ID: 38184662
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of TASL recruitment by the peptide/histidine transporter 1, PHT1.
Custódio TF; Killer M; Yu D; Puente V; Teufel DP; Pautsch A; Schnapp G; Grundl M; Kosinski J; Löw C
Nat Commun; 2023 Sep; 14(1):5696. PubMed ID: 37709742
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the role of nucleic acid antigens in murine models of systemic lupus erythematosus.
Watkins AA; Bonegio RG; Rifkin IR
Methods Mol Biol; 2014; 1169():143-58. PubMed ID: 24957237
[TBL] [Abstract][Full Text] [Related]
13. Human and Murine Toll-like Receptor-Driven Disease in Systemic Lupus Erythematosus.
von Hofsten S; Fenton KA; Pedersen HL
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791389
[TBL] [Abstract][Full Text] [Related]
14. SLC15A4 mediates M1-prone metabolic shifts in macrophages and guards immune cells from metabolic stress.
Kobayashi T; Nguyen-Tien D; Sorimachi Y; Sugiura Y; Suzuki T; Karyu H; Shimabukuro-Demoto S; Uemura T; Okamura T; Taguchi T; Ueki K; Kato N; Goda N; Dohmae N; Takubo K; Suematsu M; Toyama-Sorimachi N
Proc Natl Acad Sci U S A; 2021 Aug; 118(33):. PubMed ID: 34385317
[TBL] [Abstract][Full Text] [Related]
15. miR-31-5p Regulates Type I Interferon by Targeting SLC15A4 in Plasmacytoid Dendritic Cells of Systemic Lupus Erythematosus.
Li S; Wu Q; Jiang Z; Wu Y; Li Y; Ni B; Xiao J; Zhai Z
J Inflamm Res; 2022; 15():6607-6616. PubMed ID: 36510495
[TBL] [Abstract][Full Text] [Related]
16. Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells.
Blasius AL; Arnold CN; Georgel P; Rutschmann S; Xia Y; Lin P; Ross C; Li X; Smart NG; Beutler B
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19973-8. PubMed ID: 21045126
[TBL] [Abstract][Full Text] [Related]
17. Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activity.
Chiu TY; Lazar DC; Wang WW; Wozniak JM; Jadhav AM; Li W; Gazaniga N; Theofilopoulos AN; Teijaro JR; Parker CG
Nat Chem Biol; 2024 Jan; ():. PubMed ID: 38191941
[TBL] [Abstract][Full Text] [Related]
18. Regulation and role of the transcription factor IRF5 in innate immune responses and systemic lupus erythematosus.
Ban T; Sato GR; Tamura T
Int Immunol; 2018 Oct; 30(11):529-536. PubMed ID: 29860420
[TBL] [Abstract][Full Text] [Related]
19. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
20. Regulatory molecules required for nucleotide-sensing Toll-like receptors.
Saitoh S; Miyake K
Immunol Rev; 2009 Jan; 227(1):32-43. PubMed ID: 19120473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
